Market Review for Monday, December 29, 2025
Shared by Stephen
• December 30, 2025
Hi there,
Overview: US stocks slipped on Monday as investors moved to lock in gains from a blockbuster year. While the S&P 500 remains up over 17% for 2025, the session was marked by a shift in sentiment as markets digested recent records and prepared for the 2026 outlook. A sharp correction in gold prices also weighed on the materials sector.
📈 Major Indices
-
S&P 500: Slipped -0.35%, closing at 6,905.74.
-
Nasdaq Composite: Declined -0.50%, ending at 23,474.35.
-
Dow Jones Industrial Average: Lost -0.51%, closing at 48,461.93.
🏛️ Bonds, FX & Commodities
-
US 10-Year Yield: Declined to 4.115%, its lowest level since early December, as investors sought the safety of government debt.
-
US Dollar Index (DXY): Remained steady near 98.40, supported by end-of-year rebalancing.
-
Gold: Suffered a sharp correction, falling -4.4% to settle near $4,349.30 per ounce after hitting multiple records last week.
-
WTI Crude Oil: Remained under pressure, trading near $55.40 per barrel, maintaining its technical downtrend into the year-end.
-
Bitcoin: Saw increased volatility, trading near $88,500 after failing to hold the $90k level during the session.
📊 Specific Stock Performance
-
GOOGL (Alphabet Inc.): Down -0.8% (approx. $313.15). Faced profit-taking alongside other mega-cap tech peers after a strong December run.
-
META (Meta Platforms): Down -1.1% (approx. $671.15). Underperformed as investors trimmed positions in "2025 winners" ahead of the new year.
-
FLTR.L (Flutter Entertainment): Up +0.15% (16,690.00p). Showed resilience in the London session, bucking the downward trend seen in US-listed peers.
-
ALK (Alaska Air Group): Down -0.4% ($51.38). Drifted lower in line with the broader industrial sector.
-
PFE (Pfizer Inc.): Up +0.3% ($24.95). Caught a minor defensive bid as investors rotated out of high-growth sectors into value laggards.
-
STZ (Constellation Brands): Up +0.2% ($135.57). Stabilized after recent underperformance, showing some defensive strength.
-
NVO (Novo Nordisk ADR): Down -1.4% ($51.67). Eased back from its recent FDA-fueled surge as part of the broader healthcare sector pull-back.
Today, Tuesday, December 30, is the penultimate trading day of the year. Historically, these sessions can be volatile due to low volume and "window dressing" by fund managers.
📞 Strategy Call Assistance
If you require assistance with trade setup, risk management, or strategy review, please schedule a strategy call.
-
PREMIUM Plan Members: Strategy calls are included in your plan.
-
All Other Members: Strategy calls can be scheduled at a rate of €100 per half hour.
Happy Investing
Share Navigator Support
www.sharenavigator.ie